Brief: Medigene revises collaboration with Mitsui Norin

Medigene AG

23/03/2017 13:15

March 23 (Reuters) - Medigene AG  MDG1k.DE : 
    * Medigene revises collaboration with Mitsui Norin 
    * Today announced a new contractual arrangement with Mitsui Norin Co. Ltd, regarding its 
drug Veregen 
    * Current manufacturing and supply agreement has been mutually terminated as of March 31, 
2017 
    * Previous agreement has been replaced by a new license agreement covering drug master file 
(DMF) for Veregen 
    * As a part of arrangement to terminate existing manufacturing and supply agreement, 
Medigene has agreed to a one-time payment of $1.75 million to Mitsui Norin 
    * Additional payment to Mitsui Norin for up to $0.5 million to reimburse costs of ending 
production is also expected in course of 2017 
    * No further financial details regarding new license agreement were disclosed 
 
Source text for Eikon:  ID:nPexSsM7Ca  
Further company coverage:  MDG1k.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))